Terug
61
71
65
77
Dagbereik
€ 10,05
€ 10,31
52-Weeksbereik
€ 9,95
€ 41,80
Volume
213.156
50D / 200D Gem.
€ 11,25
/
€ 17,41
Vorige Slotkoers
€ 10,13
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,8 | 10,4 |
| P/B | 0,7 | 1,2 |
| ROE % | 164,3 | 12,4 |
| Net Margin % | 20,3 | 5,3 |
| Rev Growth 5Y % | — | 5,5 |
| D/E | 0,2 | 0,6 |
Koersdoel Analisten
Hold
€ 14,00
+38.3%
Forward K/W
7,58
Forward WPA
€ 1,34
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,13B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 1,54
€ 1,31 – € 1,73
|
2,23B | 2 |
| FY2027 |
€ 1,44
€ 1,23 – € 1,62
|
2,31B | 1 |
| FY2026 |
€ 1,34
€ 1,27 – € 1,40
|
2,13B | 5 |
No quarterly estimates available
Earnings Surprises
Last 3 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-28 | € 0,36 | € 0,36 | 0,0% |
| 2025-08-29 | € 0,09 | € 0,46 | +411,1% |
| 2025-05-30 | N/A | € 0,54 | — |
Dividend History
1 yr streakYield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 08, 2025 | Dec 15, 2025 | € 0,87 | 6,34% |
Belangrijkste Punten
Earnings grew 214,16% over the past year
ROE of 164,31% indicates high profitability
Net margin of 20,28% shows strong profitability
Debt/Equity of 0,21 — conservative balance sheet
Generating 2,60B in free cash flow
P/E of 0,75 — trading at a low valuation
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)167,35%
Earnings (1Y)214,16%
FCF Growth (3Y)796,57%
Kwaliteit
Return on Equity
164,31%
ROIC67,61%
Net Margin20,28%
Op. Margin23,27%
Veiligheid
Debt / Equity
0,21
Current Ratio2,37
Interest Coverage0,00
Waardering
P/E Ratio
0,75
Forward P/E7,58
P/B Ratio0,71
EV/EBITDA-0,81
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 167,35% | Revenue Growth (3Y) | 402,32% |
| Earnings Growth (1Y) | 214,16% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 12,41B | Net Income (TTM) | 2,52B |
| ROE | 164,31% | ROA | 38,15% |
| Gross Margin | 45,80% | Operating Margin | 23,27% |
| Net Margin | 20,28% | Free Cash Flow (TTM) | 2,60B |
| ROIC | 67,61% | FCF Growth (3Y) | 796,57% |
| Safety | |||
| Debt / Equity | 0,21 | Current Ratio | 2,37 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 1 yrs | ||
| Valuation | |||
| P/E Ratio | 0,75 | Forward P/E | 7,58 |
| P/B Ratio | 0,71 | P/S Ratio | 0,15 |
| PEG Ratio | 0,08 | Forward PEG | N/A |
| EV/EBITDA | -0,81 | Fwd EV/EBITDA | -1,43 |
| Forward P/S | 0,88 | Fwd Earnings Yield | 13,19% |
| FCF Yield | 138,12% | ||
| Market Cap | 1,88B | Enterprise Value | -2,33B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 12,41B | 4,64B | 491,65M |
| Net Income | 2,52B | 800,90M | -90,72M |
| EPS (Diluted) | 13,71 | 4,36 | -0,79 |
| Gross Profit | 5,68B | 1,97B | 133,07M |
| Operating Income | 2,89B | 1,07B | -115,84M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 6,60B | 2,94B | 393,96M |
| Total Liabilities | 3,84B | 2,53B | 701,31M |
| Shareholders' Equity | 2,65B | 408,81M | -307,42M |
| Total Debt | 548,06M | 108,84M | 63,45M |
| Cash & Equivalents | 4,75B | 2,32B | 200,75M |
| Current Assets | 5,44B | 2,65B | 275,69M |
| Current Liabilities | 2,30B | 1,45B | 297,65M |
Strategiescores
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#206 of 1049
Custom
Capital Light Compounder
#10 of 220
#96 of 826
#46 of 619
Recente Activiteit
Uitgestapt
Contrarian Investing (David Dreman)
Mar 26, 2026
Uitgestapt
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026